Hello my dear smooth brained simian simpleton! How goes the good old speculating investing? Did thou manage to get out at the top in $RIVN? No? Yes?
.jfif)
It is of no importance! We are not here for the recaps nor the pleasantries! No dear fellow, we are here to take a look at Context Therapeutics Inc ($CNTX)!
A clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States.
I hear you ponder. Well, we shall get straight into it shan't we?
The chart
Right off the bat we can see that the company is new… Brand spanking new! It IPO’d in October!
But what can the chart show is other than the price movement? Nothing... we move on!
From October's IPO till now
The price of the initial public offering was 5 million shares at $5 per share, for proceeds of $25 million.
The underwriter was granted a 45 day option to purchase said shares at the price of the IPO*.
The company began trading on the Nasdaq Capital Market on the 20th of October 2021 under the ticker “CNTX”.
Source link: Yahoo Finance
5 days after the IPO the share price was up to a high of $8.29 (~65.8% increase). However, since that high 23 days ago the stock price has plummeted back down to $4.91 (a ~ -40.8% loss to whoever bought the top)!
Now then, the “underwriter” still has till the 4th of December 2021 to exercise their seven hundred and fifty thousand options (at IPO the price of $5).
| Data provider | Shs. outstanding | Shs. Float | % increase in shs. since IPO | % shs. float |
|---|---|---|---|---|
| Finviz | 7.77M | 0.28M | ~ +55.4% | ~3.6% |
| MarketWatch | 10.96M | 293.51K | ~ +119.2% | ~2.69% |
| Yahoo Finance | 10.96M | 281.58K | ~ +119.2% | ~2.57% |
| TradingView | 10.96M | 363.11K | ~ +119.2% | ~3.31% |
Well now, very interesting. We can see that there has been some serious dilution since the IPO which was less than a month ago! We can also see that there are hardly any shares available to be bought!
Financials
It's R&D biotech, don’t be silly…
Let's have a browse over some metrics!
Source link: Finviz
Good god dear chap! It’s positively tiny! 2 employees, market cap of 38.16M, institutional interest is zilch… Oh my!
What else can we find?
We can see, through this SEC filing that the CEO owns a good portion of the company.
You can check the filings yourself and see who owns what within the company by clicking here. What else can we find about this company, so scantily spoken about?
The Chief Financial Officer and the Chief Legal Officer were appointed recently.
Ah yes! The drugs! Well as aforementioned, they are developing products for the treatment of cancer for women in the US.
Here is their pipeline for the 2 drugs they have going through clinical trials:
As you can see, both drugs are in phase II (Testing of drug on participants to assess efficacy and side effects). And the first patient has already been dosed with ONA-XR.
You can read more about both drugs here. I must admit, medicine and molecular biology is not my forté, I haven’t a clue what those drugs do precisely!
Indeed... We do dither don't we? Let’s break it down shall we?
- It's a tiny (36M mkt. cap.), brand-new biotech company with an even tinier float (280K).
- It has 2 drugs in phase II clinical trials.
And honestly, that's about it!
- Given its micro sized float it could fly on news being dropped. Watch for pumps, notice if it begins to appear in articles.
- Expect offerings on price spikes, they will seek to fill the coffers for future R&D and expenses.
- If they do come up with exceedingly impressive results further down the line, they may become a candidate for a buyout.
Well… Ermm… I ran a screener and it was the only one that popped up so I thought, what the hell!
Source link: Finviz
- Magnus Chimpski
Disclaimer: This is not financial advice. It is an opinion. Magnus is not a financial advisor.
Magnus is infact a ficticious smooth brained simian of the interwebs, to take advice from an internet monkey would be insane.
- End of transmission
Find me elsewhere:
Buy me a banana:
| Crypto | Address |
|---|---|
| Bitcoin(BTC) | 14jUKeGFgN6USdxfuT6uX8Qx3RM3gppmmt |
| Ethereum(ERC20) | 0x4c2d122c66412598486e373f885835ccbf0e1a35 |
| Doge(DOGE) | D5nCBwbKCUwm33F6hJ8tNr5rNeNb4B9XhQ |
| Shiba(ERC20) | 0x4c2d122c66412598486e373f885835ccbf0e1a35 |